termsTerm
Project FrontRunner
An FDA initiative encouraging companies to test new cancer drugs earlier in the disease, in first-line or curative settings, rather than only after everything else has failed.
Launched 2022 to shift development of novel agents to earlier lines with randomised trials and to reduce reliance on single-arm accelerated approvals in late lines.
Regulatory: what this kind of term is about · animated schematic, not to scale
Category
Regulatory
Pages like this
not linked directly; found by shared links- TermRefractory
Shares Lines of therapy, Accelerated approval.
- TermRelapsed / refractory (R/R)
Shares Lines of therapy, Accelerated approval.
- Key paperBREAKWATER: encorafenib plus cetuximab with chemotherapy as first treatment for BRAF V600E-mutated colorectal cancer
Shares Lines of therapy, Accelerated approval.